Insider Transactions in Q4 2021 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
2,879
-1.32%
|
$547,010
$190.24 P/Share
|
|
Dec 22
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,538
-5.19%
|
$477,144
$188.88 P/Share
|
|
Dec 22
2021
|
John Maraganore Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,636
-0.95%
|
$1,247,568
$188.55 P/Share
|
|
Dec 22
2021
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,538
-5.13%
|
$477,144
$188.7 P/Share
|
|
Dec 21
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+24.78%
|
-
|
|
Dec 21
2021
|
John Maraganore Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+5.7%
|
-
|
|
Dec 21
2021
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+24.57%
|
-
|
|
Dec 10
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,367
+0.61%
|
$461,562
$86.69 P/Share
|
|
Nov 12
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,978
-2.87%
|
$5,844,216
$172.3 P/Share
|
|
Nov 12
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,978
+12.02%
|
$237,846
$7.1 P/Share
|